COMUNICADO: SI-BONE, Inc. anuncia los resultados de dos años de un ensayo controlado aleatorio del iFuse Implant System® (y 2)

1. Polly DW, Swofford J, Whang PG, Frank CJ, Glaser JA, Limoni RP, Cher DJ,
Wine KD, Sembrano JN, and the INSITE Study Group. Two-Year Outcomes from
a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint
Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction. Int
J Spine Surg. 2016;10:Article 28. doi: 10.14444/3028.
2. Sachs D, Kovalsky D, Redmond A, Limoni R, Meyer SC, Harvey C, Kondrashov
D. Durable Intermediate- to Long-term Outcomes after Minimally Invasive
Transiliac Sacroiliac Joint Fusion using Triangular Titanium Implants.
Med Devices (Auckl). 2016;9:213-22. doi: 10.2147/MDER.S109267.
3. Vanaclocha-Vanaclocha V, Verdú-López F, Sánchez-Pardo M,
Gozalbes-Esterelles L, Herrera JM, Rivera-Paz M, Martínez-Gómez D.
Minimally Invasive Sacroiliac Joint Arthrodesis: Experience in a
Prospective Series with 24 Patients. J Spine. 2014;3:185. doi:
10.4172/2165-7939.1000185.
4. Rudolf L, Capobianco R. Five-Year Clinical and Radiographic Outcomes
After Minimally Invasive Sacroiliac Joint Fusion Using Triangular
Implants. Open Orthop J. 2014;8:375-83. doi: 10.2174/1874325001408010375.
5. Duhon BS, Bitan F, Lockstadt H, Kovalsky DA, Cher DJ, Hillen T, on behalf
of the SIFI Study Group. Triangular Titanium Implants for Minimally
Invasive Sacroiliac Joint Fusion: 2-year Follow-up from a Prospective
Multicenter Trial. Int J Spine Surg. 2016;10:Article 13. doi:
10.14444/3013.
6. Martin BI, Mirza SK, Comstock BA, Gray DT, Kreuter W, Deyo RA.
Reoperation rates following lumbar spine surgery and the influence of
spinal fusion procedures. Spine. 2007;32(3):382-7. doi:
10.1097/01.brs.0000254104.55716.46.

Una o más de las personas a las que se hace referencia podría ser o haber sido empleado de SI-BONE, consultor de pago, inversor, investigador de pruebas médicas o receptor de una beca. La investigación a la que se hace referencia recibió el apoyo de SI-BONE.

CONTACTO: CONTACTO: Para SI-BONE, Inc.: Joe Powers, vicepresidente demarketing, 408-207-0700, ext. 3209, jpowers@si-bone.com

Sitio Web: http://www.si-bone.com/